Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,809,790
+$95,533 QoQ
Shares Held
7,126
+1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#2,441
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HEADINVEST, LLC holds $15,409,722 across 8 Drug Manufacturers - General names. JNJ ranks #6 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
88,590 | $4,247,004 | |
| 2 | NVS |
Novartis AG
|
15,391 | $2,412,077 | |
| 3 | ABBV |
AbbVie Inc.
|
9,300 | $2,340,252 | |
| 4 | LLY |
ELI LILLY & Co
|
1,634 | $1,959,868 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,769 | $1,897,816 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
7,126 | $1,809,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,791 | $391,297 | |
| 8 | AMGN |
Amgen Inc
|
971 | $351,618 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,809,790 | 7,126 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,714,257 | 7,013 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,437,267 | 6,945 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,283,106 | 6,920 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,118,130 | 7,320 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,670,838 | 10,075 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,483,801 | 10,260 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,753,813 | 10,822 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,581,743 | 10,822 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,708,293 | 10,799 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $1,802,196 | 11,498 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,814,176 | 11,648 | Shares | Sole | 2023-12-11 | |
| 2023-06-30 | $2,941,786 | 17,773 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $3,000,025 | 19,355 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $3,410,581 | 19,307 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,164,773 | 19,373 | Shares | Sole | 2022-12-28 | |
| 2022-06-30 | $3,454,877 | 19,463 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,444,996 | 19,438 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,356,564 | 19,621 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,316,564 | 20,536 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,389,690 | 20,576 | Shares | Sole | 2021-08-30 | |
| 2021-03-31 | $3,315,761 | 20,175 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,842,282 | 18,060 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,397,116 | 16,101 | Shares | Sole | 2020-11-24 | |
| 2020-06-30 | $2,249,517 | 15,996 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,169,545 | 16,545 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||